BioWorld MedTech

Aug. 11, 2011

Med-tech faces uncertainty in healthcare landscape

ATLANTA — If there was one word that could properly describe the feelings of medical device makers across the U.S., that word would be uncertainty. (Medical Device Daily) Read More

Washington roundup: CMS eyes wider indication for extracorporeal photopheresis

International report: First Latin American use of Medtronic Symplicity performed

New ventures: Misonix now enters surgical wound debridement market

Deals roundup: Despite buyout rejection, Alere acquires more Axis-Shield stock

Financings roundup: Masimo's board authorizes repurchase of up to 3M shares

Agreements/contracts: TrovaGene stops Sequenom, regains transrenal tech rights

Grants roundup: ApoCell awarded $2.9M contract for 12 alpha prototype units

HIT roundup: Boston Sci launches NLI for spinal cord stimulation

Med-Tech Notes

People in the News

Product Briefs

Abbott Vascular gets FDA approval for RX Herculink

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan 14, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 13, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

LINC01116 has prognostic value in lung cancer, study shows

BioWorld MedTech

Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...

SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

BioWorld Science

Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...